Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients


Bisgin A., Yalcin A. D. , Gorczynski R. M.

DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.96, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 96 Konu: 3
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1016/j.diabres.2012.02.028
  • Dergi Adı: DIABETES RESEARCH AND CLINICAL PRACTICE

Özet

We examined the association between serum sTRAIL measured by ELISA and HbA1C levels, pre/post-prandial blood glucose levels and body mass index in 22 newly diagnosed type-2 diabetic patients.